Brain development was thought to be largely hardwired and accomplished by birth, and the brain was thought to have essentially no regenerative capacity. The remarkable discovery of adult neurogenesis and neural stem cells (NSCs) existing in the mature CNS changed that, allowing us to think optimistically about CNS repair. These discoveries helped to generate a robust field of neural progenitor cell biology, with relevance to CNS development, pathogenesis, the search for novel neurological therapies, as well as our understanding of how the brain works.
Brain development was thought to be largely hardwired and accomplished by birth, and the brain was thought to have essentially no regenerative capacity. The remarkable discovery of adult neurogenesis and neural stem cells (NSCs) existing in the mature CNS changed that, allowing us to think optimistically about CNS repair. These discoveries helped to generate a robust field of neural progenitor cell biology, with relevance to CNS development, pathogenesis, the search for novel neurological therapies, as well as our understanding of how the brain works.
Studies of neurodevelopment over the past two decades have produced a rich understanding of molecules important for producing specific CNS cell types in vivo. This knowledge base has impacted NSC studies in two major ways: providing an understanding of how developmental factors specify regional and temporal differences to create diverse NSCs and offspring and a rationale for applying developmental mechanisms to stimulate self-repair and to create an abundant supply of specific CNS cells ex vivo. Information on NSCs is dovetailing with studies of the ESC/IPSC-to-NSC transition, accelerating utilization of pluripotent cells for neural applications. Goal-oriented research is essential to translate these findings for patient benefit-we have the capacity to make patient-matched motor neurons for spinal cord injury or retinal cells to restore vision and to identify factors that inhibit self-renewal to prevent brain cancer growth, and it is imperative to do so. However, we must acknowledge that these goals were made achievable in large part through basic studies in developmental neuroscience and plasticity, by approaching questions such as: ''Why do male birds sing in the springtime? '' or '' What are the signals that make a hydra head or a fly with four wings instead of two?'' As we look to the future of NSC applications, inspired by what is now possible, we must remain grounded in those sustaining questions of how the nervous system forms and changes, providing a fertile ground for discovery by investigating a variety of progenitor cell systems, a variety of organisms (including humans), and keeping an open mind for serendipity and surprises. Here we highlight some of the major advances in the CNS NSC and neurogenesis field and identify some exciting future prospects.
The Brain Contains Stem Cells! In Vivo and In Vitro Studies Came Together to Illuminate a Capacity for Brain Repair
Twenty years ago, it was generally thought that, unlike other organs with regenerative capacity, the brain had little, being unable to produce new neurons after development. The concept of mature brain stability made intuitive sense: being a complex tissue with millions of intricate connections, if new neurons were added, the stability necessary for long-term storage of memories and experience seemed impossible. On this backdrop, the discovery of NSCs in the adult was a paradigm shift. Although the main idea of brain stability holds true in large part, we have come to accept that NSCs in the CNS proliferate and give rise to new neurons throughout life. In this section we discuss the major discoveries that led to acceptance of adult neurogenesis, some of the surprises that were encountered along the way, and the implications of the existence of endogenous neural stem cells.
This shift in thinking did not come easily. The history is told in detail in more comprehensive reviews (for example, Sohur et al., 2006 ) so it will be described only briefly here. In the 1960s, Joseph Altman and Gopal Das published a string of papers using [3H]-thymidine to label proliferating cells, which revealed production of ''microneurones'' or granule neurons in the hippocampal dentate gyrus (DG) and proliferating cells in the subependymal layer of the lateral ventricle (also known as the subventricular zone [SVZ] ) that ran in a band to the olfactory bulb ''as if streaming in it,'' thus first describing adult progenitor cell proliferation and migration of new olfactory neurons in the rostral migratory stream. However, the technology wasn't available to distinguish between glial cells and small granule neurons, so perhaps understandably, this early work was not immediately embraced. In the late 1970s, Michael Kaplan and James Hinds confirmed Altman and Das's findings using electron microscopy of thin sections and autoradiography to show that ultrastructurally new cells in the olfactory bulb and dentate gyrus were granule neurons with synapses from neighboring cells, suggesting functional integration. However, skepticism persisted as there was no agreement about what characteristics constitute neuronal identity, and it was unknown if synapses could form on adult glia or if [3H]thymidine could be taken up during DNA repair in mature cells. Kaplan proposed to look for neurogenesis in humans who had been given [3H]thymidine as a cancer treatment, but unfortunately, these experiments were viewed as too much for a young postdoc to handle (Kaplan, 2001) .
Major advances were made by Fernando Nottebohm and colleagues in the 1980s, who were using adult songbirds as a model system for vocal learning (Nottebohm, 2004) . Female song birds have smaller song nuclei than males, and females sing very little and have simpler songs than males. Nottebohm injected female canaries with testosterone and noticed that this induced them to sing more like males, accompanied by growth of two song control nuclei, the high vocal center (HVC), and the robust nucleus of the archipallium (RA). Furthermore, seasonal changes in the size of the nuclei were observed in male canaries. Part of this plasticity could be explained by increased dendritic arborization in the RA. But what accounted for growth in the HVC: were new cells added? To answer this question, Steve Goldman injected [3H]thymidine into testosterone-treated female canaries and observed that new cells appeared in the HVC after 30 days. At earlier time points labeled cells were observed on the wall of the lateral ventricle. This led them to conclude that, as in development, new neurons were born near the lateral ventricle and migrate up to the HVC to differentiate. The newborn cells resembled neurons at the electron microscope level. However, familiar with the skepticism encountered by Altman and Kaplan, Nottebohm expanded on these findings with John Paton in a series of brilliant experiments. A daily dose of [3H]thymidine was used to label a large number of cells in the HVC, and then birds were anesthetized and a hollow electrode was advanced into the HVC and into a cell. Once a cell was penetrated, the bird received auditory stimulation and some cells underwent an action potential in response to the sound. These cells were then filled with horseradish peroxidase via the electrode. When the brains of these birds were analyzed, some of cells that had exhibited an action potential (and were HRP labeled) were also labeled with [3H]-thymidine after autoradiography, and thus were newly born cells. The labeled cells had numerous dendrites and dendritic spines and were functionally integrated into the surrounding circuitry. Despite this supremely elegant proof, much of this work was viewed as not significant to mammals but, rather, specialized to birds.
In the early 1990s, Elizabeth Gould, then a postdoc in Bruce McEwen's lab, was investigating the effects of adrenal hormones on the hippocampus when they observed serendipitously numerous cells with neuronal morphologies being born in the rat hippocampus. Coincidently, the remarkable discovery was made that neural cells from the adult brain could be stimulated to proliferate in vitro and differentiate into neurons and glia (Reynolds and Weiss, 1992) . This evidence for a neuropotent progenitor in the adult added impetus to search for similar cells in vivo and helped renewed observations of neurogenesis in the SVZ and DG of early postnatal and adult animals gain acceptance (Kuhn et al., 1996; Alvarez-Buylla, 1993, 1994; Luskin, 1993; Suhonen et al., 1996) . The field benefited from new technologies, in particular, the use of bromodeoxyuridine (BrdU) to label proliferating cells without autoradiography, the availability of cell type specific markers, and confocal microscopy, making birthdating and cell identification easier. Finally, using brain samples from cancer patients that had received BrdU to label tumor proliferation, Fred Gage and colleagues demonstrated that neurogenesis occurs in the human hippocampus (Eriksson et al., 1998) , suggesting functional significance in humans. This was a turning point for the field of adult neurogenesis, leading not only to acceptance of the phenomenon, but to a great deal of enthusiasm and curiosity about what it could mean for brain function and repair.
Neurogenesis beyond the DG and SVZ While there is general acceptance of endogenous neurogenic stem cells and continued neuron generation in the murine DG and the olfactory system, from the SVZ and into the olfactory bulb itself, there are still important claims of other neurogenic locations that need to be resolved. Areas with reported lower levels of proliferation, such as hypothalamus and amygdala, are being explored (Fowler et al., 2008) . In humans, neurogenic stem cells can be isolated from the SVZ, but the evidence that they make new neurons in vivo is in dispute. And the notion that in any species, neurogenesis occurs in the neocortex, observed by both Altman and Kaplan in the original studies along with neurogenesis in the SVZ and DG, is still not widely held. The low level of cortical neurogenesis and the fact that the neocortex is conceptually the bastion of brain stability generated resistance. More recent studies that employed multiple immunomarkers have reported neurogenesis in rat and primate neocortex; however, these findings remain controversial, the debate centering on clear identification of these cells as neurons rather than glia. Some cells that proliferate locally express the glial progenitor marker, NG2, have small glia-like nuclei and are nestled close to larger pyramidal nuclei, leading some to conclude they are satellite glia. However, colabeling of BrdU and multiple neuronal markers such as NeuN, GABA, GAD, calbindin, and calretinin has lead others to identify these cells as small inhibitory interneurons (Cameron and Dayer, 2008; Rakic, 2002) .
Intriguingly, cells with features of NSCs can be isolated and cultured from regions outside the two main neurogenic zones, the DG and SVZ, including cortical parenchyma and spinal cord (Sohur et al., 2006) . Perhaps multipotent NSCs lie widespread throughout the mature CNS but are largely dormant, contributing to low level neuro-or gliogenesis, or perhaps rare cells can revert to this state. Establishing sites of stem cell potential in vivo is important because the strategy chosen to encourage CNS repair will be quite different based on whether we need to direct progenitor cell migration from remote zones such as the DG or SVZ or whether we can activate local progenitor cells. Both approaches show promise: newborn cells move out of neurogenic zones toward sites of ischemic injury, attracted by chemokines, such as CXCL12, and infusion of growth factors, such as BDNF, providing a means of targeting NSCs to deliver cells and their cargo. And after cortical injury or infusion of growth factors such as BDNF, CNTF, and Shh, new neurons appear in the parenchyma of cerebral cortex, adult striatum, septum, thalamus, and hypothalamus, some of which are thought to come from endogenous progenitor cells (Kokoeva et al., 2005; Sohur et al., 2006) . The hope is that with time, methods will be developed that allow precise control over this regenerative potential, to direct cells to locations of cell loss or injury, to replace appropriate cell populations, and to recreate functionality. Although many of these hurdles, in particular the connectivity problems, are significant, we must remind ourselves that any element of endogenous regenerative capacity was completely unanticipated two decades ago.
The Functional Impact of Adult Neurogenesis
One day we predict there will be a new franchise, NewBrain Inc., that caters to promoting brain enhancement. It turns out that exercise, playing with toys, avoiding stress, eating curry, and becoming pregnant are all proneurogenic, which should lead to an interesting business model. That neurogenesis persists to adulthood was exciting enough, but the discovery of environmental impact on the process was thrilling-neurogenesis was not just a constitutive phenomenon. It exhibited plasticity, and with this, the spark of purpose.
Neurogenesis encompasses cell birth, fate determination, survival, integration, and acquisition of functional properties, as described in the elegant studies of Hongjun Song and colleagues working in adult hippocampal neurogenesis by following retrovirally labeled cells through their stages of development (Duan et al., 2008) . Environmental signals can impact this process at a variety of stages. More neurons are born than survive in both the SVZ and DG, leading to a readily available pool of cells that can be selected. In her groundbreaking studies, Elizabeth Gould demonstrated that the level of newborn cells being added to the DG could be manipulated by stress and hormone levels in the adult rat, likely due to increases in glucocorticoids, which reduce progenitor cell division (Mirescu and Gould, 2006) . It would later be shown that both age and environment have an impact on neurogenesis in the rodent DG Kuhn et al., 1996) . Exercise and exposure to an enriched environment can increase survival of newborn neurons in the hippocampus and may help counter the decreases observed during aging. Environmental responsiveness suggested that adult neurogenesis is functionally important and led to inquiry into the functional relevance of newborn adult neurons.
Neurogenesis increases plasticity on multiple levels by addition of new cells and structural remodeling of neural circuits, synaptogenesis, and changes in synaptic strength. Addition of new cells to the olfactory bulb and hippocampus results in functional integration of cells with unique characteristics. For example, new dentate granule cells exhibit a lower LTP threshold than older granule cells and are insensitive to inhibition by GABA. This plasticity is thought to be important for adapting to experience, in particular for learning and memory. In general, contextual and spatial learning tasks that are hippocampal dependent enhance the survival of newborn neurons in the DG, whereas hippocampal independent learning does not. However, experiments that ablate neurogenesis have had different outcomes on hippocampal-dependent learning tasks with some researchers observing deficits and others reporting no difference from controls (Leuner et al., 2006) . Likewise, in the olfactory bulb, neurogenesis and learning are increased by an enriched odor environment, and odor deprivation decreases neurogenesis. However, again, ablation studies of bulbar neurogenesis have reported mixed effects on olfactory discrimination and learning (Imayoshi et al., 2008; Lledo and Lazarini, 2007) . The varied results might be explained by differences in species, strain, ablation techniques, and the behavioral paradigm used (Zhao et al., 2008) . In addition, broad ablation techniques that impact both olfactory and hippocampal regions confound: in the future, precise ablation of neurogenesis in specific regions should help elucidate the roles of each neurogenic system to behavioral adaptation.
Deducing the functional impact of neurogenesis has wideranging implications, from placement of Wiis in retirement homes, aiming to increase exercise and maintain a healthy level of neurogenesis, to an appreciation of how drugs impact the system. The cognitive impairment resulting from chemotherapy, for example, may result in part from killing endogenous progenitor cells, and screening for agents that attack this system minimally will be a boon (Dietrich et al., 2006) . Some antidepressants increase neurogenesis, and studies of the impact of a variety of neuroactive drugs are just beginning. The future for this area of research is fodder for fascinating speculation. Will we be able to eliminate age-related memory loss, boost brain power, combat depression, or perhaps develop an exquisite sense of smell?
NSCs In Vitro, Birth of the Neurosphere, and Production of Neurons and Glia in the Dish An important point of debate among developmental neuroscientists in the 1980s, which had been reverberating in embryology circles for about a century, was whether there was a common progenitor for neurons and glial cells. To resolve this and other fundamental questions of progenitor biology, prior to retroviral lineage tracing, some researchers, including a pioneer in the field, Martin Raff, decided to take a reductionist approach to characterize progenitor cell types isolated from the brain in vitro to determine their developmental potential (the types of cells they can produce), proliferative potential, response to exogenous growth factors, and how fate choices are made. The dogma at the time, however, was that neuronal progenitor cells would simply stop dividing and differentiate once they were placed in tissue culture (TC). Then, there were few resources for neural cell culture, it was a rather precarious process-practically a culinary art-and we have to acknowledge the TC pioneers who defined media for neural cells and enabled in vitro studies to go forward. As ex vivo growth of NSCs and their progeny, derived either from the nervous system or from pluripotent stem cells, is necessary to produce the large numbers of animal and human cells anticipated for a variety of neuroscience and neurotherapeutic applications, the development of specialized stem cell culture media and reagents will continue to be an important area for innovation.
Extracting progenitor cells from the nervous system and providing them with growth factors in vitro established a controlled system to approach important questions about their fundamental characteristics. Clonal culture studies of progenitors from the embryonic mouse basal forebrain showed that the nervous system contained highly prolific, multipotent, self-renewing cells (McKay, 1997; Temple, 2001 ). These results, combined with the discovery that multipotent progenitor cells can be cultured from adult brain as floating multicellular spheres called neurospheres (Reynolds and Weiss, 1992) , provided critical evidence that the CNS contained stem cells. Although this review is focused on the CNS, studies in the PNS, where neural crest stem cells were discovered early and continuing neurogenesis was recognized in the olfactory epithelium, helped pave the way to acceptance of the central phenomenon.
In vitro studies have become a staple method for investigating mechanisms of NSC self-renewal and differentiation. Establishment of human neural lines has provided a much-needed resource for translational studies (Jakel et al., 2004) . More complex coculture systems allow us to ask questions about cell-cell interactions, which is leading to development of 3D TC systems for modeling aspects of neural diseases and as a surrogate for drug screening on CNS tissue, for testing toxicity, and for efficacy. Some of the most exciting advances in NSC research will likely come from involvement of bioengineers who bring new technologies to the TC realm. Self-assembling nanofibers for scaffolding cell growth, hydrogels, and artificial microenvironments functionalized with bioactive molecules such as laminin fragments, are just a few of the projects that foreshadow what is likely to be an explosion in methods to grow and manipulate NSCs, both in vitro and transplanted in vivo (Ashton et al., 2007a; Cullen et al., 2007; Tysseling-Mattiace et al., 2008) .
The neurosphere assay has been widely adopted as a facile measure of NSC activity. While important questions concerning the origin of neurosphere-forming cells remain-for example, exactly which cells they correspond to in vivo-the discovery of a nontransformed cell that can grow in nonadherent conditions, from the brain no less, led to a veritable sphere-fest, with a similar approach yielding floating multicell growths from a variety of tissues. It will be intriguing to figure out what engenders sphere-forming ability in diverse progenitor cell subtypes and whether this will expose properties of normal cells that predispose to oncogenesis. The neurosphere assay is still being improved in order to distinguish progenitor cells from self-renewing stem cells and to ensure clonality. It also forms the basis of novel directions such as creating arrays of patterned neurosphere cultures for high-throughput screening for factors impacting self-renewal or fate choices (Ashton et al., 2007b; Saxe et al., 2007) . The fact that neurospheres are almost as easy to grow as sea monkeys has enabled many new researchers entrance to the NSC field to provide valuable comparative information with other stem cell types as well as innovative interdisciplinary approaches to NSC biology.
Identity of NSCs: Changing How We View Fundamental CNS Classes
Demonstrating a subpopulation of progenitors with stem cell characteristics begs the question as to the identity of these cells in vivo. Twenty years ago, we understood the embryonic CNS germinal zone to contain neuroepithelial ventricular zone progenitor cells as neuronal precursors, which migrated along radial glial as guiding cells, and SVZ progenitors as largely glial precursors. Where might stem cells fit into this picture? With the advent of immunomarkers for major subpopulations of CNS cells and fluorescent reporters enabling visualization of live cells, these cardinal viewpoints were changed. Unexpectedly, radial glial cells were identified as the principle progenitor cell in embryonic germinal zones, producing neurons and neuroblasts that frequently underwent their terminal division in the SVZ, as well as glia (reviewed in Noctor et al., 2007) . That radial glia included the stem cell population was underscored by lineage tracing of these cells into the adult SVZ (Merkle et al., 2004) . Presently, it is not possible to point to which specific radial glial cells are stem cells; however, we are beginning to describe subpopulations, for example, those that respond to Notch signaling via canonical or noncanonical pathways (Mizutani et al., 2007) and based on transcriptome analysis (Pinto et al., 2008) . Refinement of functional and expression markers will produce a fuller understanding of radial glia subtypes during development.
A further surprise concerned the identity of adult NSCs. In the adult avian brain, a radial glial-like cell in the ventricular zone divides to give rise to a neuroblast that then uses the radial fiber to migrate to the HVC and throughout the telencephalon. Pursuing this question in mammals, Fiona Doetsch, then a graduate student in Arturo Alvarez-Buylla's lab, performed an elegant series of experiments that included ultrastructural studies and lineage tracing, leading to the conclusion that adult brain progenitor cells were GFAP+ and thus related to astrocytes (Doetsch et al., 1999) . A controversy arose as to whether some ependymal cells, multiciliate cells which abut the ventricle, were stem cells in the adult forebrain, a dispute that was actually highlighted in the New York Times in a science editorial in 1999 (underscoring the well-known erudition of New Yorkers) and an idea that continues to find support. However, it appears that SVZ astrocytes are intercalated frequently with ependymal cells in the germinal zone and can proliferate to regenerate the ependymal lining if damaged, e.g., in aging (Luo et al., 2008) . Thus, while multicilate ependymal cells in the germinal region, when viewed at the EM level, do not appear to proliferate (Doetsch et al., 1999; Luo et al., 2008; Spassky et al., 2005) , this epithelial layer includes proliferative NSCs (Mirzadeh et al., 2008) , providing a possible coherence between the two ideas. As the cells lining the ventricle in other regions, such as spinal cord, are indicated to have progenitor properties that are activated upon injury (Meletis et al., 2008) , it will be important to perform in depth ultrastructural analysis with multiple immunomarkers to identify the proliferating cell types within it. Importantly, two types of ciliated ependymal cells have been identified in the adult SVZ, E1 cells with 32-73 cilia and E2 cells with only two cilia and a complex basal body (Mirzadeh et al., 2008) . Consequently, it is plausible that the ventricular lining will be regionally varied, with different populations of multiciliate ependymal cells and possibly other admixed cell types. This highlights how NSC studies are leading us to a fuller understanding of CNS cell biology and to question our established interpretation of cell classes and cell function.
Unequivocal identification of NSCs will depend on establishing new markers. Identifying some of the genes expressed in stem cells-including GFAP, Nestin, GLAST, Sox2, CD133, Musashi, and LeX-has allowed enrichment of acutely isolated cells, and gene array analysis of these cells can be used to generate an understanding of unique markers or combinations that can generate secure identification for NSCs. Comparison of these cells to mature populations, including astrocytes, will be highly valuable to identify biological functions that are unique to NSCs and could underlie their critical functions of self-renewal and fate determination. Recent single-cell gene expression studies are an exciting advance that should help to further define stem cells and their progeny (Kawaguchi et al., 2008) .
Moving Through: Adult NSC Lineage Progression and Plasticity
In the adult SVZ, a relatively quiescent GFAP-positive stem cell (a Type B cell) gives rise to a more rapidly proliferative transit amplifying cell (Type C cell) that expands the progenitor pool and produces Type A neuroblasts that divide and migrate in the rostral migratory stream toward the olfactory bulb. There they differentiate into granule neurons that integrate into the granule layer
Neuron 60, November 6, 2008 ª2008 Elsevier Inc. 423 or periglomerular neurons in the glomerular layer (Alvarez-Buylla and Lim, 2004) . SVZ Type B cells also produce oligodendrocytes destined for the overlying corpus callosum, the striatum, and fimbria fornix (Menn et al., 2006) . In the hippocampus, two populations of progenitor cells exist in the subgranular zone. Type 1 cells are Sox2+, relatively quiescent cells that resemble radial glia in that they are GFAP-positive and send a long process through the granule layer into the overlying molecular layer. Type 2 cells also express Sox2 but are GFAP-negative and lack radial processes and proliferate more readily. The lineage relationship between Type 1 and Type 2 cells is being elucidated. Both cells appear to give rise to neuroblasts which migrate into the granule cell layer and mature into glutamatergic granule neurons that project to the CA3 and hilar regions (Zhao et al., 2008) .
In the future, we anticipate more detailed lineage trees, as studies are improving our understanding of the subtypes of progenitor cells in these zones. For example, Cre-mediated lineage tracing of adult SVZ progenitor cells reveals different embryonic regional origins, each contributing to different subtypes of interneurons in the olfactory bulb (reviewed in Lledo et al., 2008) . These studies suggest there is an intrinsic heterogeneity within the SVZ progenitor cells. Indeed, transcription factors including Pax6, Mash1, Olig2, ER81, Dlx1/2, Dlx5/6, and Emx1 are differentially expressed in subpopulations of cells in the SVZ Young et al., 2007; Parras et al., 2004; Stenman et al., 2003) , playing roles in determining diversity of neuronal subtypes in the olfactory bulb. With more characterization, we expect that different types of adult SVZ progenitor cells can be defined by combinatorial expression of cell surface markers and transcription factors, which will further our understanding of the lineage relationships and specific outcomes of adult neurogenesis.
Maintenance of and transition between these basic compartments is regulated by exogenous growth factors (see niche section) and also cell-intrinsic regulatory factors. A timely review summarizes the impact of epigenetic factors such as regulatory RNAs and histone-modifying enzymes on stem cell self-renewal and differentiation (Namihira et al., 2008) . Factors that expand the progenitor pool by increasing self-renewal, such as Notch signaling or the polycomb protein Bmi-1 (Molofsky et al., 2004) , may act in part via regulating the incidence of symmetric proliferative versus asymmetric cell divisions from NSCs, a concept for which there is good evidence in embryonic germinal zones (Zhong and Chia, 2008) but which remains to be tested in the adult. The fate of progenitor cells can be altered by manipulating gene expression. For example, in the adult SVZ, enforced expression of Pax6 enhances neurogenesis, while expression of Olig2 or reduction of Smad4 in NSC promotes oligogenesis (Colak et al., 2008; Hack et al., 2005) . Not only can cell choices be regulated in this manner, but cell fate can be reprogrammedfor example, expression of Ascl1/Mash1 in the hippocampal dentate gyrus can make these cells differentiate into oligodendrocytes in vivo, a fate that they would normally rarely acquire (Jessberger et al., 2008) , and remarkably, expression of Bmi-1 in astrocytes can induce the appearance of cells with NSC features (Moon et al., 2008) . As we learn more about the essential genes needed to reprogram cells into specific phenotypes, this approach could extend the potential of adult NSCs enormously.
Much of the foregoing work on adult NSC lineage progression has been deduced from genetic lineage tracing methods and static images. The dynamic nature of the process, including cell division mode and regulation, changes in cell morphology and position, and migratory behavior of cell subclasses, is an exciting new area of exploration. Imaging wholemounts of SVZ is beginning to provide real-time information about regulatory molecules that impact this dynamic process (Nam et al., 2007; Platel et al., 2008) .
Stem Cells Ensconced
Within the adult neurogenic niches, neural stem cells proliferate and produce neurons appropriate for their destination. However when removed from their niche and plated in culture or transplanted into another region, NSCs from the SVZ generate largely glial progeny (Herrera et al., 1999) . Conversely, stem cells derived from nonneurogenic regions such as spinal cord, when transplanted into the adult hippocampus, generate granule neurons (Shihabuddin et al., 2000) . These landmark experiments have shown that extrinsic factors in the neurogenic stem cell niche play a critical role in regulating stem cell behavior and act in an instructive manner. Interestingly, adult SVZ cells can make hippocampal neurons when placed into the hippocampus, and hippocampus-derived stem cells can make olfactory neurons after transplantation into the RMS (Suhonen et al., 1996) , indicating molecular signals may be niche-specific. Given these findings, it is crucial to understand the nature of the adult NSC niche and the tissue-specific extracellular signals in order to understand how stem cell self-renewal and neurogenesis are regulated during normal aging and in the diseased brain.
Stem cell niches have been well characterized in a variety of tissues and across different species. In the relatively simple invertebrate stem cell systems, such as those of Drosophila melanogaster and Caenorhabditis elegans, individual stem cells are countable and can be identified by genetic tags, allowing components of stem cell niches to be characterized precisely at the single-cell level. It is more difficult in mammals, especially for the nervous system, to definitively identify individual stem cells in vivo due to lack of highly specific markers. Nevertheless, based on ultrastructural properties and basic cell-type markers, a clearer picture of the structure and properties of adult neural niches is beginning to emerge. Recent studies provide a better understanding of the direct physical interaction and molecular communication in the SVZ niche (Mirzadeh et al., 2008; Shen et al., 2008; Tavazoie et al., 2008 ). An extensive blood vessel network is revealed using 3D wholemount imaging (Shen et al., 2008; Tavazoie et al., 2008) , confirming that it is a vascular niche as observed in hippocampus and songbird neurogenic zones (reviewed in Riquelme et al., 2008) . Interestingly, at the sites where NSCs and their progeny contact the vasculature, the blood-brain barrier lacks astrocyte endfeet and pericyte coverage, a modification unique to the SVZ (Tavazoie et al., 2008) , suggesting SVZ cells may have easier access to blood-borne signals. A subset of GFAP-expressing cells, the stem cellcontaining population, is intercalated within the ependymal layer in a honeycomb-like pattern (Shen et al., 2008) , some forming a unique pinwheel organization specific to regions of adult neurogenesis (Mirzadeh et al., 2008) . These cells are in close proximity to blood vessels either via their somas or basal processes and are thus in a distinct position to receive signals from both the CSF and the SVZ blood vessels.
It is perhaps not surprising that some of the central signaling pathways that function during development of the nervous system such as Notch, Wnt, BMP, and Shh signaling pathways also play significant roles in adult neurogenesis (see reviews Pozniak and Pleasure, 2006; Zhao et al., 2008) . The cellular origins and targets of these signaling molecules are an active area of research. Moreover, the same factor can have different effects, for example, Noggin, expressed in the dentate gyrus and the ependymal cells in the SVZ, promotes neurogenesis through inhibition of BMP signaling (Lim et al., 2000) , while directed knockout of the BMP effector Smad4 in adult SVZ NSCs can inhibit neurogenesis (Colak et al., 2008) , indicating a complexity of action that might vary based on how factors are presented, at what level, and to which targets. Besides these usual suspects, other factors have been identified as players in the adult niche that are less well recognized as morphogenic signals in brain development. For example, PEDF, a secreted factor expressed by endothelial cells and ependymal cells in the adult SVZ, promotes NSC self-renewal in vitro and in vivo (RamirezCastillejo et al., 2006) . We anticipate many more regulatory factors will be uncovered, some unique to the adult niche where proximity to CSF, choroid plexus, subventricular zone vascular plexus, and locally somewhat leaky vessels (Tavazoie et al., 2008) provide a complex molecular environment.
Understanding the niche signals will make it possible to create a microenvironment that encourages neurogenesis, which will be a crucial factor for designing new strategies to activate endogenous NSCs and to facilitate neurogenesis from transplanted cells. Notably, if Noggin, BDNF, or FGF2 are ectopically expressed in the striatal parenchyma, a nonneurogenic region, and NSCs are transplanted into this site, the transplanted cells show enhanced neuron generation (Chmielnicki et al., 2004; Gritti et al., 2002; Lawson et al., 2007) . Uncovering aspects of the parenchyma that are inhibitory to neurogenesis, such as Ephrin expression (Jiao et al., 2008) , will also help advance this aim. These findings will guide in vitro construction of artificial instructive microniches to help determine growth of stem cells in culture or after implantation into the injured CNS. And they provide information that can be used to combat stem-like cells in brain cancers; for example, application of BMP can stimulate differentiation in some gliomas, thus inhibiting tumor growth (Piccirillo et al., 2006) . Importantly, we need to understand how these various extracellular signals are chaperoned and coordinated in the 3D stem cell niche, which is a relatively unexplored frontier, and how the effects of multiple factors are integrated by the recipient cells.
Making CNS Cells to Order: Dendrites with That? Over the past 20 years, the field of developmental neurobiology has made great strides. Advances in molecular biology and the ability to generate mutant and transgenic animals have resolved fundamental problems concerning regional patterning and progenitor behavior. Once basic CNS regional compartments are established via signal gradients, the progenitor cells within them proliferate and differentiate into regionally appropriate cell types more or less autonomously. It was shown that regional information is encoded in NSCs and that while it can be changed to some limited extent by environmental factors, e.g., upon heterotopic transplantation, it is a fundamental and characteristic property of NSCs (Urbach and Technau, 2008) .
In addition to regional specification, studies also demonstrated that NSCs and progenitors isolated from a variety or neural regions, for example from retina and cortex, become increasingly specialized over time. Thus, early cells can produce most of the cell types in that region and do so in the correct temporal order, while later cells become gradually restricted (Pearson and Doe, 2004) . Remarkably, the timing mechanism is intrinsically stored in individual cells, which can recapitulate the order even in clonal culture (Shen et al., 2006) . NSCs generate neurons by undergoing a series of asymmetric cell divisions, and they can produce different cell types at each division, followed by a dramatic asymmetric cell division that changes their output from neuronal to glial generation. The timing of the switch from neurogenesis to gliogenesis is intrinsically programmed; for example, the COUP-TFI/II genes are required for ES-derived NSCs and embryonic forebrain NSCs to respond to gliogenic signals (Naka et al., 2008) , similar to the role of NF1A in the developing spinal cord (Deneen et al., 2006) , but is also dependent on environmental factors, such as release of cardiotrophin-1 from cortical neurons (Barnabe-Heider et al., 2005) .
Overall, the picture that is emerging is of a vast variety of NSC types that are regionally and temporally specified as an essential step in the production of specific types of neurons and glia during development. This knowledge is helping us design strategies to produce specific types of CNS cell from ESCs and iPSCs. ESCs produce an early neural lineage progenitor, recognized as a rosette-forming cell that can be regionally patterned (Elkabetz et al., 2008) . Growth of ESCs in conditions that yield forebrain progeny also results in temporally ordered appearance of cortical cells (Gaspard et al., 2008; Eiraku et al., 2008) , much as seen from cortical NSCs, emphasizing the inherent fundamental temporal programs. Characterizing this heterogeneity and understanding the molecular basis of regional and temporal patterning is one of the most important goals of NSC biology. This is the information that will be needed to reprogram cells to a specified neural fate (Table 1) .
Many of the specific applied goals for utilizing NSCs require the production of a homogenous population of cells for experimental drug testing or to produce a select cell subtype, such as nigral dopaminergic cells for cell-replacement therapies. Methods to generate large numbers of single cell types from neural precursors will have to take into account the natural tendency of these cells to diversify when left to their own devices. Even directed reprogramming of NSCs or expanded neural progenitor populations toward a single cell class might be difficult to attain, given their inherent heterogeneity. It might be easier, at least theoretically, to take a more homogenous cell type, such as fibroblasts, and imprint them to instill specific aspects of a desired neural phenotype, a possibility that once seemed unimaginable, but with the extraordinary discovery of induced pluripotency, now seems attainable. However, in the more immediate future, traditional approaches are being pursued, such as developing culture conditions and selection methods to enrich for neural cell subtypes derived from NSCs. While ESCs and iPSCs allow production of vast numbers of progeny, the unlimited proliferative potential of these pluripotent cells is a double-edged sword, and utilization in vivo will require a high bar of assurance against tumor formation. In contrast, NSC-derived cells have a lower proliferative potential and, in some regards, are closer to clinical applications; for example, the first clinical trial for lysosomal storage disease is ongoing. The use of NSCs in clinical therapies is a complex issue (Guillaume et al., 2008; Selden, 2008) ; however, that we are now at the point of discussing the hurdles involved in using these cells illustrates the remarkable progress we have made in this 20 year journey.
Conclusion
The nervous system is a most provocative and complex organ. There is a wealth of knowledge about cell types and disposition, the function of specific parts, and the interactions between areas. Consequently, we can approach questions in stem cell science that can't be asked or just aren't as meaningful in other systems. For example, the question of fine spatial placement is difficult to rationalize in gut or skin, but identifying stem cells in a particular region of the nervous system automatically has incumbent implications: are the cells in a memory-forming region or an area involved in motor programs or visual processing? Similarly, we can approach questions of cell niche or context with more layers of understanding-identifying the cell types and signaling molecules involved, the molecules that pass from neurons, glia, microglia, or blood cells to NSCs have deep implications, given the wealth of background information on nervous system physiology. Thus, we can ask nuanced questions about stem cell biology within the nervous system, for example, regarding the relative role of stem cells during development and into adulthood; the molecular basis of self-renewal and how this is regulated depending on NSC sub-type; how (Emsley and Hagg, 2003; Shimazaki et al., 2001) Noggin SVZ neurogenesis (Lim et al., 2000) Noggin+BDNF SVZ striatal medium spiny neurons (Chmielnicki et al., 2004) EGF SVZ astrocytes; conversion of type c cells; oligodendrocytes (Aguirre and Gallo, 2007; Doetsch et al., 2002; Kuhn et al., 1997) PDGF SVZ type B cell proliferation, Oligodendrocytes (Jackson et al., 2006) bFGF SVZ neurogenesis BMP SVZ neurogenesis/gliogenesis (Colak et al., 2008; Lim et al., 2000) Wnt SVZ/HC proliferation/neurogenesis (Adachi et al., 2007; Lie et al., 2005) SHH SVZ/HC proliferation (Ahn and Joyner, 2005; Lai et al., 2003; Machold et al., 2003; Palma et al., 2005) PEDF SVZ self-renewal (Ramirez-Castillejo et al., 2006) RNA/DNA Delivery Mash1 HC oligodendrocytes (Jessberger et al., 2008) Pax6 SVZ dopaminergic periglomeral neurons (Hack et al., 2005; Kohwi et al., 2005) Olig2 SVZ oligodendrocytes (Hack et al., 2005) Dlx2 SVZ dopaminergic periglomeral neurons TLR2/4 SiRNA SVZ/HC neurogenesis (Rolls et al., 2007) miRNA124, miRNA 137 SVZ neurogenesis (Silber et al., 2008) Reprogramming Genes Oct4/Klf4 5 days postnatal brain pluripotent cells Small Molecules VPA AHP neurogenesis/Ygliogenesis (Hsieh et al., 2004) Fluoxetine HC neurogenesis (Santarelli et al., 2003) Cyclopamine HC Yproliferation (Lai et al., 2003) Isoxazoles AHP neurogenesis/Ygliogenesis (Schneider et al., 2008) This is not an exhaustive list, but serves to identify the various types of factors that have been used to change NSC fate. In the future, we anticipate development of families of small molecules that will mimic environmental and intrinsic factors, allowing reprogramming of NSCs to specific neural fates with enhanced potential to repair even in the adult injured environment, summoning the advent of NSCs as cell medicines. AHP, Adult Hippocampal Progenitor in vitro; HC, Hippocampus.
developmental potential is encoded, programmed, and changed to generate the vast diversity of neural cells; and the structure and role of the niche. Pursuit of these questions should bring many intriguing answers, which will in turn lead to the sorts of goal-oriented science necessary to achieve advances in neural cell therapies. Looking back over the past 20 years, many of the most outstanding advances in the NSC field have the following characteristics: they were surprises that led to a reevaluation of well established principles, many emerged serendipitously from a diverse array of experimental biological systems, and many were led by creative young people with a fresh view. Perhaps this is a common story in scientific progress, providing even more reason to extend the trend: progress in NSC biology, we predict, will depend on recruiting enthusiastic scientists who are unafraid to question dogma or to address fundamental questions in neurodevelopment. The impact of this field will be enormous, and it is a most exciting and rewarding place for our brightest minds. Let us encourage young scientists into the NSC field by ensuring that funding is available to a large number of individual investigators working in a variety of experimental systems to create a fertile ground for discovering the next leaps forward in NSC biology.
